Equip Your Preclinical I/O Studies with Robust Models to Enable Enhanced Clinical Relevancy and Translatability As the only industry-focused meeting dedicated to preclinical scientists and translational oncologists in the immunotherapy space, the PREDiCT Series is once again delighted to bring to you Tumor Models San Francisco 2021. Running in a digital capacity this year, the 5th PREDiCT: Tumor Models San Francisco 2021 Summit enables you to discover the latest I/O preclinical strategies in the biopharmaceutical industry, evaluate and debate next-generation preclinical models for immuno-oncology studies and form high-quality connections to ensure cooperation and collaboration stays alive in a socially-distant world. Offering a wide range of content-driven presentations, expert-led Q and A and discussion, interactive workshops, and the provision of networking opportunity, benchmark against your fellow colleagues to advance your I/O candidates towards the clinic. https://tumor-models-sf.com/ 26-28 January, 2021 8am-6pm PST | 11am-9pm EST Contact: info@hansonwade.com Pricing: Drug Developers (Earlybird rates and workshops available) - $1999 Academic (Earlybird rates and workshops available) - $1799 Model and Service Providers (Earlybird rates and workshops available) - $2499 URL: Brochure: https://go.evvnt.com/687560-0?pid=5528 Time: 08:00 - 18:00